{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:47:52Z","timestamp":1792226872206,"version":"4.4.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T00:00:00Z","timestamp":1717545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T00:00:00Z","timestamp":1717545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100024078","name":"Kyowa Kirin Farmac\u00e9utica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024078","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-024-01962-3","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T10:01:46Z","timestamp":1717581706000},"page":"1251-1260","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["X-Linked hypophosphatemia. Data from a Spanish adult population cohort"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5986-8811","authenticated-orcid":false,"given":"Luis Carlos","family":"L\u00f3pez-Romero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Jes\u00fas","family":"Broseta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan R.","family":"Mu\u00f1oz-Casta\u00f1eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Hern\u00e1ndez-Jaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,6,5]]},"reference":[{"key":"1962_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2019.03.009","author":"A Rothenbuhler","year":"2020","unstructured":"Rothenbuhler A, Schnabel D, H\u00f6gler W, Linglart A (2020) Diagnosis, treatment-monitoring and follow-up of children and adolescents with X-linked hypophosphatemia (XLH). Metabolism. https:\/\/doi.org\/10.1016\/j.metabol.2019.03.009","journal-title":"Metabolism."},{"issue":"11","key":"1962_CR2","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/nrneph.2010.121","volume":"6","author":"AS Alizadeh Naderi","year":"2010","unstructured":"Alizadeh Naderi AS, Reilly RF (2010) Hereditary disorders of renal phosphate wasting. Nat Rev Nephrol 6(11):657\u2013665. https:\/\/doi.org\/10.1038\/nrneph.2010.121","journal-title":"Nat Rev Nephrol"},{"issue":"4\u20135","key":"1962_CR3","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/BF02405074","volume":"35","author":"PJ Marie","year":"1983","unstructured":"Marie PJ, Glorieux FH (1983) Relation between hypomineralized periosteocytic lesions and bone mineralization in vitamin D-resistant rickets. Calcif Tissue Int 35(4\u20135):443\u2013448. https:\/\/doi.org\/10.1007\/BF02405074","journal-title":"Calcif Tissue Int"},{"key":"1962_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2019.154049","volume":"103S","author":"AL Lecoq","year":"2020","unstructured":"Lecoq AL, Brandi ML, Linglart A, Kamenick\u00fd P (2020) Management of X-linked hypophosphatemia in adults. Metabolism 103S:154049. https:\/\/doi.org\/10.1016\/j.metabol.2019.154049","journal-title":"Metabolism"},{"issue":"6","key":"1962_CR5","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41574-022-00662-x","volume":"18","author":"A Trombetti","year":"2022","unstructured":"Trombetti A, Al-Daghri N, Brandi ML, Cannata-And\u00eda JB, Cavalier E, Chandran M, Chaussain C, Cipullo L, Cooper C, Haffner D, Harvengt P, Harvey NC, Javaid MK, Jiwa F, Kanis JA, Laslop A, Laurent MR, Linglart A, Marques A, Mindler GT, Minisola S, Yerro MCP, Rosa MM, Seefried L, Vlaskovska M, Zanchetta MB, Rizzoli R (2022) Interdisciplinary management of FGF23-related phosphate wasting syndromes: a consensus statement on the evaluation, diagnosis and care of patients with X-linked hypophosphataemia. Nat Rev Endocrinol 18(6):366\u2013384. https:\/\/doi.org\/10.1038\/s41574-022-00662-x","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"1962_CR6","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/bcp.13763","volume":"85","author":"EA Imel","year":"2019","unstructured":"Imel EA, White KE (2019) Pharmacological management of X-linked hypophosphataemia. Br J Clin Pharmacol. 85(6):1188\u20131198. https:\/\/doi.org\/10.1111\/bcp.13763","journal-title":"Br J Clin Pharmacol."},{"issue":"8","key":"1962_CR7","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/jbmr.3475","volume":"33","author":"KL Insogna","year":"2018","unstructured":"Insogna KL, Briot K, Imel EA, Kamenick\u00fd P, Ruppe MD, Portale AA, Weber T, Pitukcheewanont P, Cheong HI, Jan de Beur S, Imanishi Y, Ito N, Lachmann RH, Tanaka H, Perwad F, Zhang L, Chen CY, Theodore-Oklota C, Mealiffe M, San Martin J, Carpenter TO, AXLES 1 Investigators (2018) A randomized, double-blind, placebo-controlled, phase 3 trial evaluating the efficacy of burosumab, an anti-FGF23 antibody, in adults with X-linked hypophosphatemia: week 24 primary analysis. J Bone Miner Res. 33(8):1383\u20131393. https:\/\/doi.org\/10.1002\/jbmr.3475","journal-title":"J Bone Miner Res."},{"issue":"1","key":"1962_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13052-019-0654-6.PMID:31151476;PMCID:PMC6545008","volume":"45","author":"F Emma","year":"2019","unstructured":"Emma F, Cappa M, Antoniazzi F, Bianchi ML, Chiodini I, Eller Vainicher C, Di Iorgi N, Maghnie M, Cassio A, Balsamo A, Baronio F, de Sanctis L, Tessaris D, Baroncelli GI, Mora S, Brandi ML, Weber G, D\u2019Ausilio A, Lanati EP (2019) X-linked hypophosphatemic rickets: an Italian experts\u2019 opinion survey. Ital J Pediatr 45(1):67. https:\/\/doi.org\/10.1186\/s13052-019-0654-6.PMID:31151476;PMCID:PMC6545008","journal-title":"Ital J Pediatr"},{"key":"1962_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2019.03.009","volume":"103S","author":"A Rothenbuhler","year":"2020","unstructured":"Rothenbuhler A, Schnabel D, H\u00f6gler W, Linglart A (2020) Diagnosis, treatment-monitoring and follow-up of children and adolescents with X-linked hypophosphatemia (XLH). Metabolism 103S:153892. https:\/\/doi.org\/10.1016\/j.metabol.2019.03.009","journal-title":"Metabolism"},{"key":"1962_CR10","doi-asserted-by":"publisher","unstructured":"Jose Jesus Broseta (2021) Different approaches to improve cohort identification using electronic health records: X-linked hypophosphatemia as an example,\u00a0Intractable & Rare Diseases Research,\u00a02021,\u00a0Volume 10,\u00a0Issue 1,\u00a0Pages 17\u201322,\u00a0Released on J-STAGE March 04, 2021,\u00a0Advance online publication January 17, 2021,\u00a0Online ISSN 2186\u2013361X. 2186\u20133644,\u00a0https:\/\/doi.org\/10.5582\/irdr.2020.03123.","DOI":"10.5582\/irdr.2020.03123"},{"issue":"4S","key":"1962_CR11","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2024) KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 105(4S):S117\u2013S314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018","journal-title":"Kidney Int."},{"issue":"1","key":"1962_CR12","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s13023-020-01434-4.PMID:32605590;PMCID:PMC7329472","volume":"15","author":"R Padidela","year":"2020","unstructured":"Padidela R, Nilsson O, Makitie O, Beck-Nielsen S, Ariceta G, Schnabel D, Brandi ML, Boot A, Levtchenko E, Smyth M, Jandhyala R, Mughal Z (2020) The international X-linked hypophosphataemia (XLH) registry (NCT03193476): rationale for and description of an international, observational study. Orphanet J Rare Dis 15(1):172. https:\/\/doi.org\/10.1186\/s13023-020-01434-4.PMID:32605590;PMCID:PMC7329472","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"1962_CR13","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1210\/jcem.81.11.8923863","volume":"81","author":"MP Whyte","year":"1996","unstructured":"Whyte MP, Schranck FW, Armamento-Villareal R (1996) X-linked hypophosphatemia: a search for gender, race, anticipation, or parent of origin effects on disease expression in children. J Clin Endocrinol Metab 81(11):4075\u20134080. https:\/\/doi.org\/10.1210\/jcem.81.11.8923863","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1962_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.reuma.2019.07.007","volume":"17","author":"LC L\u00f3pez-Romero","year":"2021","unstructured":"L\u00f3pez-Romero LC, Broseta JJ, Guill\u00e9n Olmos E, Devesa-Such RJ, Hern\u00e1ndez-Jaras J (2021) X-linked hypophosphatemic rickets: diagnosis in adult and paucisymptomatic form. Reumatol Clin. 17(2):116\u2013117. https:\/\/doi.org\/10.1016\/j.reuma.2019.07.007. (English, Spanish)","journal-title":"Reumatol Clin."},{"issue":"12","key":"1962_CR15","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1157\/13086324","volume":"126","author":"JM Haro","year":"2006","unstructured":"Haro JM, Palac\u00edn C, Vilagut G, Mart\u00ednez M, Bernal M, Luque I, Codony M, Dolz M, Alonso J, y el Grupo ESEMeD-Espa\u00f1a (2006) Prevalencia de los trastornos mentales y factores asociados: resultados del estudio ESEMeD-Espa\u00f1a. Med Clin 126(12):445\u2013451","journal-title":"Med Clin"},{"issue":"7","key":"1962_CR16","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1007\/s11136-020-02465-x","volume":"29","author":"SH Lo","year":"2020","unstructured":"Lo SH, Lachmann R, Williams A, Piglowska N, Lloyd AJ (2020) Exploring the burden of X-linked hypophosphatemia: a European multi-country qualitative study. Qual Life Res. 29(7):1883\u20131893. https:\/\/doi.org\/10.1007\/s11136-020-02465-x","journal-title":"Qual Life Res."},{"issue":"1","key":"1962_CR17","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s13023-022-02452-0","volume":"17","author":"MIL Yanes","year":"2022","unstructured":"Yanes MIL, Diaz-Curiel M, Peris P, Vicente C, Marin S, Ramon-Krauel M, Hernandez J, Broseta JJ, Espinosa L, Mendizabal S, Perez-Sukia L, Mart\u00ednez V, Palaz\u00f3n C, Pi\u00f1ero JA, Calleja MA, Espin J, Arborio-Pinel R, Ariceta G (2022) Health-related quality of life of X-linked hypophosphatemia in Spain. Orphanet J Rare Dis 17(1):298. https:\/\/doi.org\/10.1186\/s13023-022-02452-0","journal-title":"Orphanet J Rare Dis"},{"key":"1962_CR18","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1067\/mpd.2003.119","volume":"142","author":"C Chaussain-Miller","year":"2003","unstructured":"Chaussain-Miller C et al (2003) Dental abnormalities in patients with familial hypophosphatemic vitamin D-resistant rickets: prevention by early treatment with 1-hydroxyvitamin D. J Pediatr 142:324\u2013331","journal-title":"J Pediatr"},{"key":"1962_CR19","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.bone.2019.06.025","volume":"127","author":"S DeLacey","year":"2019","unstructured":"DeLacey S, Liu Z, Broyles A, El-Azab SA, Guandique CF, James BC, Imel EA (2019) Hyperparathyroidism and parathyroidectomy in X-linked hypophosphatemia patients. Bone. 127:386\u2013392. https:\/\/doi.org\/10.1016\/j.bone.2019.06.025","journal-title":"Bone."},{"issue":"13","key":"1962_CR20","doi-asserted-by":"publisher","first-page":"1004624","DOI":"10.3389\/fendo.2022.1004624","volume":"2","author":"Y Takashi","year":"2022","unstructured":"Takashi Y, Toyokawa K, Oda N, Muta Y, Yokomizo H, Fukumoto S, Kawanami D (2022) Combined treatment by burosumab and a calcimimetic can ameliorate hypophosphatemia due to excessive actions of FGF23 and PTH in adult XLH with tertiary hyperparathyroidism: a case report. Front Endocrinol (Lausanne) 2(13):1004624. https:\/\/doi.org\/10.3389\/fendo.2022.1004624","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"1962_CR21","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1210\/js.2018-00338","volume":"3","author":"GP Colares Neto","year":"2019","unstructured":"Colares Neto GP, Ide Yamauchi F, Hueb Baroni R, de Andrade BM, Cavalanti Gomes A, Chammas MC, Matsunaga MR (2019) Nephrocalcinosis and nephrolithiasis in X-linked hypophosphatemic rickets: diagnostic imaging and risk factors. J Endocr Soc 3(5):1053\u20131061. https:\/\/doi.org\/10.1210\/js.2018-00338","journal-title":"J Endocr Soc"},{"key":"1962_CR22","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S0022-3476(99)70060-0","volume":"135","author":"L Patzer","year":"1999","unstructured":"Patzer L et al (1999) Urinary supersaturation of calcium oxalate and phosphate in patients with X-linked hypophosphatemic rickets and in healthy schoolchildren. J Pediatr 135:611\u2013617","journal-title":"J Pediatr"},{"issue":"10189","key":"1962_CR23","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/S0140-6736(19)30654-3","volume":"393","author":"EA Imel","year":"2019","unstructured":"Imel EA, Glorieux FH, Whyte MP, Munns CF, Ward LM, Nilsson O, Simmons JH, Padidela R, Namba N, Cheong HI, Pitukcheewanont P, Sochett E, H\u00f6gler W, Muroya K, Tanaka H, Gottesman GS, Biggin A, Perwad F, Mao M, Chen CY, Skrinar A, San Martin J, Portale AA (2019) Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial. Lancet. 393(10189):2416\u20132427. https:\/\/doi.org\/10.1016\/S0140-6736(19)30654-3. (Erratum in: Lancet. 2019 Jul 13;394(10193):120)","journal-title":"Lancet."},{"issue":"3","key":"1962_CR24","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1210\/clinem\/dgab729","volume":"107","author":"A Linglart","year":"2022","unstructured":"Linglart A, Imel EA, Whyte MP, Portale AA, H\u00f6gler W, Boot AM, Padidela R, Van\u2019t Hoff W, Gottesman GS, Chen A, Skrinar A, Scott Roberts M, Carpenter TO (2022) Sustained efficacy and safety of burosumab, a monoclonal antibody to FGF23, in children with X-linked hypophosphatemia. J Clin Endocrinol Metab 107(3):813\u2013824. https:\/\/doi.org\/10.1210\/clinem\/dgab729","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1962_CR25","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41581-019-0152-5","volume":"15","author":"D Haffner","year":"2019","unstructured":"Haffner D, Emma F, Eastwood DM, Duplan MB, Bacchetta J, Schnabel D, Wicart P, Bockenhauer D, Santos F, Levtchenko E, Harvengt P, Kirchhoff M, Di Rocco F, Chaussain C, Brandi ML, Savendahl L, Briot K, Kamenicky P, Rejnmark L, Linglart A (2019) Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol 15(7):435\u2013455. https:\/\/doi.org\/10.1038\/s41581-019-0152-5","journal-title":"Nat Rev Nephrol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-01962-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-024-01962-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-01962-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:53:52Z","timestamp":1777564432000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/37\/5\/1251\/8306740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,5]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["1962"],"URL":"https:\/\/doi.org\/10.1007\/s40620-024-01962-3","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,5]]},"assertion":[{"value":"1 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have received research grants from Kyowa Kirin International. L.C.L-R. and J.R. M-C. have received lecture fees from Kyowa Kirin Spain, J.J.B. has received lecture fees and advisory fees from Kyowa Kirin Spain and Kyowa Kirin International.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was authorized by La Fe Health Research Institute and was conducted in accordance with the ethical principles of the Declaration of Helsinki and data protection regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants agreed to participate by signing the corresponding informed consent form.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}